Oasmia Pharmaceutical AB (Oasmia)

Oncology Corporate Profile

HQ Location

Vallongatan 1
Upsalla, Sweden SE-752 28

Company Description

Oasmia Pharmaceutical AB develops new generations of drugs in the field of human and veterinary oncology. The company’s product development aims to create and manufacture novel nanoparticle formulations and drug-delivery systems based on well-established cytostatics, which, in comparison with current alternatives, show improved properties, reduced side effects, and expanded applications. The company’s product development is based on its proprietary in-house research and company patents.

Website: http://oasmia.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
paclicalmitotic inhibitorOvarian cancerIII
paclicalmitotic inhibitorBrain cancerI
doxophysanthracycline antibioticBreast cancerPreclinical

View additional information on product candidates here »

Pipeline image

Source


http://oasmia.com/

Recent News Headlines

There are no news items to display